TumorGen is developing a novel drug discovery platform to identify unseen therapeutic targets associated with cancer metastasis. Our patented technology is used to capture circulating metastatic cancer cell clusters (MCCCs). The MCCCs have been shown to be the primary vector for disseminating distant metastases in most solid tumor cancers. Our innovative platform can open an entirely new therapeutic target space for biopharma developing drugs directly impacting the pathways of cancer metastasis.